The weekly litigation news digest is live. Subscribe now

IP Verse

Qiagen Sciences competitive analysis

Loading summary...

Latest patents of Qiagen Sciences opposed by its competitors

Explore Qiagen Sciences's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 20, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP3580350
Nov 18, 2020Polymerase Enzyme From Pyrococcus Furiosus1

Latest PTAB cases involving Qiagen Sciences

Discover the latest PTAB cases involving Qiagen Sciences, highlighting their recent legal challenges and patent disputes.

Last updated on: Nov 19, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Qiagen Sciences

IPR2025-00026Oct 10, 2024QIAGEN SCIENCESTECAN GROUPTrial Instituted
IPR2025-00027Oct 10, 2024QIAGEN SCIENCESTECAN GROUPTerminated-Adverse Judgment
IPR2025-00028Oct 10, 2024QIAGEN SCIENCESTECAN GROUPTrial Instituted
IPR2025-00029Oct 10, 2024QIAGEN SCIENCESTECAN GROUPTrial Instituted

Peer Comparison New

IP litigation analysis comparing Qiagen Sciences with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 20, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
QIAGEN SCIENCES - 14 -
MAIWALD136 - - -
TECAN GROUP - - - 9